Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Univax Biologics Inc.
Bharat Pandya of Kemper Securities raised UNVX to "strong buy"
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury